InsMed Surge and Brinsupri Launch

Both the risk-on crypto space and the risk-off defensive staples sector getting hit today. What the dual downer means for the market, and how the Fast Money traders are positioning for November. Plus Shares of Insmed nearly tripling in 2025. What the CEO sees in store for the company as they rollout their chronic lung disease drug.

Fast Money Disclaimer

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.